On ECHEMI
Home > Drugs > Leuprorelin acetate Registered Holders
Leuprorelin acetate structure

Leuprorelin acetate structure

Leuprorelin acetate

Leuprolide acetate is a potent gonadotropin-releasing hormone receptor agonist used for the treatment of prostate cancer, endometriosis, uterine fibroids.

Find 37 Related Holders

TAKEDA PHARMACEUTICAL CO LTD
United States United States

API Registration Country

API Active
POLYPEPTIDE LABORATORIES INC
United States United States

API Registration Country

API Active
ZHEJIANG PEPTITES BIOTECH CO LTD
United States United States

API Registration Country

API Active
POLYPEPTIDE LABORATORIES SWEDEN AB
United States United States

API Registration Country

API Active
Sun Pharmaceutical Industries Ltd
United States United States

API Registration Country

API Active
AURO PEPTIDES LTD
United States United States

API Registration Country

API Active
REALI TIDE BIOLOGICAL TECHNOLOGY WEIHAI CO LTD
United States United States

API Registration Country

API Active
SpecGx LLC
United States United States

API Registration Country

API Inactive
TEVA PHARMACEUTICAL INDUSTRIES LTD
France France

API Registration Country

API Inactive
  • Founded in:

    2020-03-01 00:00:00
  • Country:

    France France
  • Address:

    5 BASEL STREET PETACH TIKVA ISRAËL
  • Email:

GENZYME CORP.
Brazil Brazil

API Registration Country

API Inactive
  • Country:

    Brazil Brazil
  • Address:

    NAO INFORMADO, EXTERIOR - EX
  • Email:

Recommended Suppliers of Leuprorelin acetate
View 27 Suppliers Request for Quotation
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.